As of 2024-12-11, the Intrinsic Value of Utah Medical Products Inc (UTMD) is
66.81 USD. This UTMD valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 63.69 USD, the upside of Utah Medical Products Inc is
4.90%.
The range of the Intrinsic Value is 60.53 - 76.19 USD
66.81 USD
Intrinsic Value
UTMD Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
60.53 - 76.19 |
66.81 |
4.9% |
| DCF (Growth 10y) |
68.00 - 86.12 |
75.29 |
18.2% |
| DCF (EBITDA 5y) |
84.46 - 121.78 |
104.61 |
64.2% |
| DCF (EBITDA 10y) |
88.22 - 128.38 |
108.76 |
70.8% |
| Fair Value |
22.50 - 22.50 |
22.50 |
-64.67% |
| P/E |
139.23 - 231.62 |
173.81 |
172.9% |
| EV/EBITDA |
98.73 - 144.87 |
121.10 |
90.1% |
| EPV |
99.07 - 119.81 |
109.44 |
71.8% |
| DDM - Stable |
22.30 - 44.53 |
33.42 |
-47.5% |
| DDM - Multi |
23.79 - 37.49 |
29.14 |
-54.2% |
UTMD Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
215.91 |
| Beta |
0.49 |
| Outstanding shares (mil) |
3.39 |
| Enterprise Value (mil) |
127.46 |
| Market risk premium |
4.60% |
| Cost of Equity |
12.11% |
| Cost of Debt |
5.00% |
| WACC |
8.06% |